Herold Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Herold Advisors's LLY Position: Q1 2026 in Review
Herold Advisors reduced its Eli Lilly (LLY) stake by 2.4% in Q1 2026, selling an estimated $254K and leaving 10,193 shares worth $9.38M. The position accounts for 2.06% of the portfolio, ranked #5.
Herold Advisors first reported a position in LLY in Q3 2021 and has held it in 19 quarters since. The position peaked at $11.2M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Herold Advisors held 10,193 shares of Eli Lilly worth $9.38M as of Q1 2026.
- Herold Advisors sold 251 Eli Lilly shares in Q1 2026, an estimated $254K.
- Eli Lilly made up 2.06% of Herold Advisors's portfolio in Q1 2026, its #5 holding.
- Herold Advisors first reported a position in Eli Lilly in Q3 2021 and has held it in 19 quarters since.
- Herold Advisors's Eli Lilly position peaked at $11.2M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Herold Advisors's 13F filing for Q1 2026, filed 15 May 2026.